English
Spain
Filter
Showing 31–45 of 63 results
Participants will be able to identify critical quality attributes (CQA), define critical process parameters (CPP), apply risk assessment and design of experiments (DoE), establish design space, and implement control strategies to ensure optimized and scalable pharmaceutical processes.
Participants will be able to apply ICH-based Quality Risk Management principles, conduct risk assessments using structured tools, integrate risk controls into quality systems, document risk decisions, and maintain a proactive risk-based compliance culture.
Participants will be able to align development strategy with IND, NDA, and ANDA requirements, understand data expectations across development stages, support regulatory documentation, and reduce development risks through early regulatory integration.
Participants will be able to develop qualification protocols, execute IQ, OQ, and PQ activities for laboratory equipment, apply risk-based approaches, ensure proper documentation, and maintain a validated state throughout the equipment lifecycle.
Participants will be able to implement the three-stage process validation lifecycle, define critical process parameters, design validation protocols, analyze process data statistically, and maintain continued process verification aligned with regulatory expectations.
Pharmaceutical Quality Management System
Participants will be able to design and manage a robust pharmaceutical QMS, integrate risk-based decision-making, strengthen deviation and CAPA processes, ensure documentation control, and maintain inspection readiness aligned with global regulatory standards.
Participants will be able to apply SPC tools, construct and interpret control charts, evaluate process capability indices, detect process trends, and integrate statistical monitoring into pharmaceutical quality and validation systems.
Participants will be able to understand core biostatistical concepts, interpret clinical trial data, differentiate between statistical and clinical significance, evaluate study results critically, and collaborate effectively with biostatistics teams.
Participants will be able to understand clinical documentation requirements, manage Trial Master Files effectively, apply document lifecycle controls, ensure regulatory compliance, and maintain audit-ready systems throughout the clinical trial process.
Participants will be able to apply GDP principles, implement ALCOA+ requirements, write structured and compliant technical documents, prevent documentation errors, and maintain inspection-ready records in accordance with global pharmaceutical regulations.
Participants will be able to interpret and apply ICH-GCP guidelines, ensure ethical conduct of clinical trials, maintain compliant documentation, manage protocol adherence, and prepare for regulatory inspections effectively.
Participants will be able to implement risk-based stability strategies, manage global stability commitments, perform statistical shelf-life analysis, handle excursions and investigations, and ensure inspection readiness across product lifecycle stages.
Participants will be able to design advanced stability protocols, conduct statistical trend analysis, manage deviations and temperature excursions, ensure data integrity compliance, and maintain inspection readiness throughout the product lifecycle.
Stability Operations for Pharmaceutical Quality
Participants will be able to develop compliant stability protocols, monitor stability programs, interpret data trends, determine shelf life, and handle deviations effectively while maintaining audit readiness.
Participants will be able to apply GLP and GDP requirements accurately across laboratory and documentation workflows, produce clear and compliant technical documents, and evaluate records for data integrity and inspection readiness. They will strengthen their ability to prevent documentation-related deviations and respond confidently to regulatory scrutiny.